- Some error occured
We are looking for qualified partners to support the licensing (CTD/eCTD dossier) and/or contract manufacturing of an established topical NSAID formulation:
-
Diclofenac diethylamine 2.32% gel
-
Dosage form: topical gel, 180 g tube
-
Therapeutic area: local treatment of pain and inflammation (musculoskeletal conditions, sports injuries, joint and muscle pain)
-
Regulatory status: OTC
-
Target markets: EU, MENA, CIS
-
Regulatory pathway: national procedures or MRP/DCP
We are seeking:
-
Ready-to-register or previously approved dossiers (CTD/eCTD format)
-
GMP-certified contract manufacturing capabilities for semisolid formulations (gels)
-
Support with bulk production, tube filling, and secondary packaging
-
Optional: assistance with variations, local adaptation, QRD compliance
Preferred manufacturing region: Europe or Turkey